Showing results (1661-1670 of 1,814) with videos related to
Sort By:
Pageof 182
Journal for Immunotherapy of Cancer|June 20, 2020
Chronic immune checkpoint inhibitor pneumonitisJarushka Naidoo, Tricia R Cottrell, Evan J Lipson, et al.Cell Reports|September 10, 2024
Aged fibroblast-derived extracellular vesicles promote angiogenesis in melanomaLaura Hüser, Yash Chhabra, Olesia Gololobova, et al.Clinical Lung Cancer|January 14, 2017
RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 PatientsMichal Sarfaty, Assaf Moore, Victoria Neiman, et al.Nature Medicine|March 17, 2023
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancerZoe June F Assaf, Wei Zou, Alexander D Fine, et al.Cancer Immunology Research|August 26, 2021
Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker DiscoveryNicolas A Giraldo, Sneha Berry, Etienne Becht, et al.Journal for Immunotherapy of Cancer|February 26, 2025
Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020Paolo A Ascierto, Hao Tang, Sonia Dolfi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2024
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial DataGeorgina V Long, Evan J Lipson, F Stephen Hodi, et al.The Oncologist|April 18, 2015
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapiesSiraj M Ali, Eric M Sanford, Samuel J Klempner, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 2025
Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year updateEvan J Lipson, F Stephen Hodi, Hussein Tawbi, et al.The New England Journal of Medicine|April 19, 2018
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPDDavid A Lipson, Frank Barnhart, Noushin Brealey, et al.Pageof 182